The Shiwarski Tissue Engineering Lab has secured two pilot grants from the Hemophilia Center of Western Pennsylvania (HCWP) through the P3HVB Pilot Grant program. Both awards take effect June 1, 2026, and together expand the lab’s research into hemostasis and inherited bleeding and clotting disorders.

The first award provides $50,000 for the project “Development of a Novel Point-of-Care Biomarker Assay for Predicting Bleeding Risk in Inherited Bleeding Disorders.” Dr. Daniel Shiwarski leads this work with co-PIs Dr. Julia Xu and Dr. Nikki Machin, with the goal of developing a point-of-care assay that predicts bleeding risk in patients with inherited bleeding disorders.

The second award renews the lab’s ongoing project, “Development of a Collagen-Based 3D Bioprinted Model System to Study Hemostasis & Inherited Clotting Disorders,” for a second year, co-led with Drs Sruti Shiva and Nikki Machin. The HCWP approved a $75,000 extension to continue and expand the collagen-based bioprinted model system, building on the lab’s collagen bioprinting work and successful progress in their original pilot award.

The lab thanks the HCWP review committee, VMI, Department of Bioengineering, and its collaborators for their continued support of this research.